GlassScriptPhysician profile
Raymond V Paolini
NPI 1609837863
$11,699.82
in general payments reported to CMS, 2019-2025
17 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,006 · 2020: $709 · 2021: $353 · 2022: $6,406 · 2023: $1,456 · 2024: $1,246 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,610 · Travel and Lodging: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,609.94 |
| Travel and Lodging | $616.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $5,933.64 | 2019-2024 | |
| Intersect Ent, INC. | $1,133.75 | 2019-2022 | |
| Medical Device Business Services, INC. | $616.59 | 2023 | |
| Acclarent, INC | $614.04 | 2022-2023 | Trudi Nav Cable, Relieva Tract |
| Aerin Medical INC. | $562.84 | 2020-2024 | |
| Smith+Nephew, INC. | $552.15 | 2019-2024 | Halo, Coblation |
| Genzyme Corporation | $473.94 | 2019-2025 | |
| Medtronic, INC. | $430.88 | 2023-2025 | Pteye Parathyroid Detection System, Sinuva, Propel |
| Glaxosmithkline, LLC. | $391.18 | 2021-2025 | Nucala |
| Stryker Corporation | $275.15 | 2019-2024 | Xpress Ent Dilation System, Scopis Ent |
| Integra Lifesciences Corporation | $267.52 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Regeneron Healthcare Solutions, INC. | $172.19 | 2019-2025 | Dupixent |
| Alk-Abello, INC | $115.00 | 2020 | |
| Abbvie INC. | $111.65 | 2024 | |
| Paratek Pharmaceuticals, INC. | $21.90 | 2025 | Xhance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.42 | 2025 | Tezspire |
| Karl Storz Endoscopy-America | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Paolini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.